DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 153 filers reported holding DIPLOMAT PHARMACY INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,925,000 | -59.1% | 392,928 | -49.1% | 0.02% | -57.1% |
Q2 2019 | $4,702,000 | -25.9% | 772,134 | -29.3% | 0.04% | -22.2% |
Q1 2019 | $6,346,000 | -59.6% | 1,092,180 | -6.3% | 0.04% | -64.6% |
Q4 2018 | $15,695,000 | -77.1% | 1,166,027 | -67.0% | 0.13% | -71.3% |
Q3 2018 | $68,619,000 | +39.8% | 3,535,217 | +84.1% | 0.44% | +27.0% |
Q2 2018 | $49,090,000 | -37.8% | 1,920,572 | -51.0% | 0.35% | -39.5% |
Q1 2018 | $78,969,000 | +2.9% | 3,919,051 | +2.5% | 0.58% | +2.5% |
Q4 2017 | $76,751,000 | -8.2% | 3,824,190 | -5.3% | 0.56% | -7.0% |
Q3 2017 | $83,611,000 | -0.5% | 4,037,213 | -28.9% | 0.60% | -1.8% |
Q2 2017 | $84,023,000 | -3.4% | 5,677,230 | +4.1% | 0.61% | -4.5% |
Q1 2017 | $87,015,000 | – | 5,455,461 | – | 0.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |